XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Changes in Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in-Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non- controlling Interests in Consolidated Entities
Beginning balance (in shares) at Dec. 31, 2020   353,500,000        
Beginning balance at Dec. 31, 2020 $ 2,930.2 $ 3.5 $ 2,546.2 $ 348.2 $ (208.7) $ 241.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares) (600,000) (600,000)        
Shares repurchased $ (25.0)     (25.0)    
Equity-based compensation 75.5   75.5      
Shares issued for equity-based awards (in shares)   1,600,000        
Contributions 44.4         44.4
Distributions (220.3)     (177.4)   (42.9)
Net income 1,837.4     1,794.3   43.1
Currency translation adjustments (23.2)       (22.6) (0.6)
Defined benefit plans, net 3.0       3.0  
Ending balance (in shares) at Jun. 30, 2021   354,500,000        
Ending balance at Jun. 30, 2021 4,622.0 $ 3.5 2,621.7 1,940.1 (228.3) 285.0
Beginning balance (in shares) at Mar. 31, 2021   354,500,000        
Beginning balance at Mar. 31, 2021 3,712.2 $ 3.5 2,573.7 1,118.8 (234.0) 250.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares)   (300,000)        
Shares repurchased (15.0)     (15.0)    
Equity-based compensation 48.0   48.0      
Shares issued for equity-based awards (in shares)   300,000        
Contributions 40.7         40.7
Distributions (116.3)     (88.7)   (27.6)
Net income 946.5     925.0   21.5
Currency translation adjustments 4.7       4.5 0.2
Defined benefit plans, net 1.2       1.2  
Ending balance (in shares) at Jun. 30, 2021   354,500,000        
Ending balance at Jun. 30, 2021 $ 4,622.0 $ 3.5 2,621.7 1,940.1 (228.3) 285.0
Beginning balance (in shares) at Dec. 31, 2021 355,367,876 355,400,000        
Beginning balance at Dec. 31, 2021 $ 5,706.2 $ 3.6 2,717.6 2,805.3 (247.5) 427.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares) (2,400,000) (2,400,000)        
Shares repurchased $ (105.3)     (105.3)    
Equity-based compensation 85.0   85.0      
Shares issued for equity-based awards (in shares)   3,300,000        
Shares issued for performance allocations (in shares)   700,000        
Shares issued for performance allocations 36.5   36.5      
Shares issued related to the acquisition of CBAM (in shares)   4,200,000        
Shares issued related to the acquisition of CBAM 194.5   194.5      
Contributions 166.9         166.9
Distributions (363.7)     (207.1)   (156.6)
Net income 843.7     817.0   26.7
Currency translation adjustments (127.5)       (109.3) (18.2)
Defined benefit plans, net $ (4.0)       (4.0)  
Ending balance (in shares) at Jun. 30, 2022 361,245,965 361,200,000        
Ending balance at Jun. 30, 2022 $ 6,432.3 $ 3.6 3,033.6 3,309.9 (360.8) 446.0
Beginning balance (in shares) at Mar. 31, 2022   361,700,000        
Beginning balance at Mar. 31, 2022 6,354.3 $ 3.6 2,982.4 3,207.0 (283.0) 444.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares repurchased (in shares)   (700,000)        
Shares repurchased (24.9)     (24.9)    
Equity-based compensation 46.0   46.0      
Shares issued for equity-based awards (in shares)   100,000        
Shares issued for performance allocations (in shares)   100,000        
Shares issued for performance allocations 5.2   5.2      
Contributions 20.1         20.1
Distributions (127.1)     (117.6)   (9.5)
Net income 248.9     245.4   3.5
Currency translation adjustments (87.7)       (75.3) (12.4)
Defined benefit plans, net $ (2.5)       (2.5)  
Ending balance (in shares) at Jun. 30, 2022 361,245,965 361,200,000        
Ending balance at Jun. 30, 2022 $ 6,432.3 $ 3.6 $ 3,033.6 $ 3,309.9 $ (360.8) $ 446.0